Incyte`s Phase 3 frontMIND Tafasitamab Trial Hits PFS Goal
13 Jun 2026 //
BUSINESSWIRE
CDSCO Approves Enhertu for First-line HER2-Positive Breast Cancer
13 Jun 2026 //
EXPRESSPHARMA
Chiesi Group Complete Acquisition KalVista Pharma for $1.9B
13 Jun 2026 //
CONTRACTPHARMA
Heart drug developer Kardigan targets $1.4B valuation in US
13 Jun 2026 //
REUTERS
Neion Bio raises $23M Series A to make proteins from chicken eggs
13 Jun 2026 //
GLOBENEWSWIRE
Race to Launch Weight-Loss Pill Heats up as Novo wins UK approval
13 Jun 2026 //
REUTERS
Takeda`s AI-crafted Psoriasis Pill tops BMS` Sotyktu
13 Jun 2026 //
REUTERS
Ractigen Presents saRNA as Obesity Treatment Frontier at ADA`26
05 Jun 2026 //
PR NEWSWIRE
Pacira Reminds Stockholders to Vote BLUE Proxy Ahead of AGM
04 Jun 2026 //
PR NEWSWIRE
Drugs In Development
Market Intel

Market Place
Sourcing Support